Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
CEREW was delisted on the 30th of August, 2021.
0 hedge funds and large institutions have $0 invested in Cerevel Therapeutics Holdings, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 22 closing their positions.
100% less funds holding
Funds holding: 22 → 0 (-22)
100% less capital invested
Capital invested by funds: $45M → $0 (-$45M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 22
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.04M |
| 2 |
BlackRock
New York
|
-$3.41M |
| 3 |
6CM
683 Capital Management
New York
|
-$3.36M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.36M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.18M |
CEREW Hedge Fund Activity: Q3 2021 in Review
0 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) for Q3 2021, worth a combined $0 — down 100% from $45M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of CEREW and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Federated Hermes, exiting entirely with an estimated $4.04M sold.
- 0 institutional investors held Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) as of Q3 2021, down from 22 in Q2 2021.
- Funds reported $0 of Cerevel Therapeutics Holdings, Inc. Warrant stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new Cerevel Therapeutics Holdings, Inc. Warrant positions in Q3 2021 and 22 closed out, a net change of -22 holders.
- The largest Cerevel Therapeutics Holdings, Inc. Warrant seller in Q3 2021 was Federated Hermes, an estimated $4.04M sold.
Based on aggregated 13F filings for Q3 2021.